Related Experiment Videos
Progressive pleural thickening during oxprenolol therapy.
British Journal of Diseases of the Chest
|April 1, 1979
Summary
Progressive pleural thickening was observed in a patient undergoing oxprenolol treatment. This case suggests a potential link between oxprenolol and the development of pleural abnormalities.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Oxprenolol is a beta-adrenergic receptor antagonist used for cardiovascular conditions.
- Pleural thickening is a pathological condition affecting the pleura, the membranes surrounding the lungs.
Observation:
- A case study detailing a patient who developed progressive pleural thickening.
- The onset of pleural changes coincided with the patient's treatment regimen involving oxprenolol.
Findings:
- The described case highlights a potential adverse effect of oxprenolol.
- A possible association between oxprenolol use and the development of progressive pleural thickening is discussed.
Implications:
- This finding warrants further investigation into the potential pleurotoxic effects of oxprenolol.
- Clinicians should be vigilant for pleural abnormalities in patients treated with oxprenolol.